Regulatory ApprovalLucentis® biosimilar FYB201/Ranivisio® (ranibizumab) approved in Brazil 05.06.2025 / 06:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Press ...

Based Protocol for Men Interested in Supporting Vascular and Tissue Health CHARLOTTE, NC / ACCESS Newswire / June 4, 2025 / In an era of growing demand for non-pharmaceutical health technologies, The ...

JRM Construction Management is excited to announce the successful completion of a comprehensive renovation project of the ...

The large molecule drug substance CDMO market is anticipated to expand at a CAGR of ~9% during the forecast period. Key ...

The pharmaceutical excipients market is projected to grow at a CAGR of 6% from 2025 to 2030, driven by the increasing demand ...

The transcatheter mitral valve replacement (TMVR) market is projected to grow at a CAGR of 20% over the forecast ...

The nutraceutical CDMO market is anticipated to expand at a CAGR of ~8% during the forecast period. Key drivers of this ...

The minimally invasive cardiac surgery market is projected to grow at a 5-10% CAGR over the forecast period. Major factors ...

The HLA typing market is projected to grow at a CAGR of ~6% over the forecast period. Major factors driving the growth ...

The global immuno-oncology market is set to witness a growth rate of 21% in the next 5 years. Increasing incidence and ...

GSK has partnered with IT services provider adesso to develop DREAM (Digital Reminders for Adherence of Medicines and ...

The point-of-care ultrasound devices market is projected to grow at a CAGR of ~7% over the forecast period. Major factors ...